BetaGlue Therapeutics News and Activities

View the org chart displaying its 15 main executives

Most searched biographies at BetaGlue Therapeutics

• Alexis Peyroles, Chief Executive Officer and Director
• Francesco Berri, Director
• Colin Story, Director

Popular executive movements at BetaGlue Therapeutics

• Alexis Peyroles, who was Director, is promoted to Chief Executive Officer and Director  (posted on September 23 2025).
• Colin Story who was Chief Executive Officer and Director, becomes Director  (posted on September 23 2025).

Create your alert
to follow the executive moves at BetaGlue Therapeutics.

BetaGlue Therapeutics has 2,405 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Vertex Pharmaceuticals (United States (USA)).

Popular M&A news in Biotechnology

• Ona Therapeutics has just announced a $87 Million fundraising (posted on June 5 2026).
• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Carl Gordon - Director at Odyssey Therapeutics

Learn more about the Biotechnology industry

Press releases by BetaGlue Therapeutics

• BetaGlue renews Board of Directors, appoints Dr. Colin Story

Social media about BetaGlue Therapeutics

• BetaGlue Therapeutics on Wikipedia, Google News & Yahoo Finance
• BetaGlue Therapeutics on LinkedIn, X (Twitter) & YouTube